Home > Insider Trading > Filing (0001144204-13-027972)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
868278	Prophase Labs Inc.	PRPH	Pharmaceutical Preparations (2834)	232577138

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1459632	S Mark Leventhal	621 N. Shady Retreat Road Doylestown PA 18901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	Acquisiton	2013-05-08	8,696	$1.60	178,696	No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.
Common Stock, Par Value $0.0005	Acquisiton	2013-05-09	1,304	$1.60	180,000	No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.
No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	270,195	Direct

Footnotes

The reporting person has corrected his beneficial ownership information in this Form 4 to disclose that 20,000 shares that were reported as individually owned in a Form 4 filed with the Securities and Exchange Commission on November 30, 2012 were actually owned by the Mark S & Donna R Leventhal Family Foundation Inc.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.